Sudarshan Pharma Industries LtdBSE: SUDARSHAN

Announcement under Regulation 30 (LODR)-Issue of Securities

· Issued by Sudarshan Pharma Industries Ltd via BSE India

Filed with BSE ·

In continuation of the outcome of Board Meeting held on 10-Jan-2025, Fund Raising Committee of the Board at its meeting held on 30-Jan-2025 approved, inter alia, revision in list of allottees and change in Notice of EGM and issue of Corrigendum to the Notice of Extraordinary General Meeting scheduled on Tuesday, 04-Feb-2025.

View Attachment

6ix hasn’t read this filing yet.

View original source (BSE India)Sudarshan Pharma Industries Ltd on 6ix

Earlier from Sudarshan Pharma Industries

Later from Sudarshan Pharma Industries

All Sudarshan Pharma Industries news releases